@nathandenbroeder.bsky.social
We manually chart-reviewed the circumstances of newly occurring very abnormal results. We found that almost always, patients had a clear reason for higher pre-test chances of finding abnormalities (see table), suggesting testing could be performed on indication or omitted (for known abnormalities).
August 26, 2025 at 11:18 AM
We manually chart-reviewed the circumstances of newly occurring very abnormal results. We found that almost always, patients had a clear reason for higher pre-test chances of finding abnormalities (see table), suggesting testing could be performed on indication or omitted (for known abnormalities).
Our paper on lab monitoring during DMARD use is published in Annals of Internal Medicine today! doi.org/10.7326/ANNA...
With n=4774 patients, 18383 patient-years and almost 60k lab sets, we found that very abnormal results are rare and associated with indicators of overtesting. #rheumatology
With n=4774 patients, 18383 patient-years and almost 60k lab sets, we found that very abnormal results are rare and associated with indicators of overtesting. #rheumatology
August 26, 2025 at 11:18 AM
Our paper on lab monitoring during DMARD use is published in Annals of Internal Medicine today! doi.org/10.7326/ANNA...
With n=4774 patients, 18383 patient-years and almost 60k lab sets, we found that very abnormal results are rare and associated with indicators of overtesting. #rheumatology
With n=4774 patients, 18383 patient-years and almost 60k lab sets, we found that very abnormal results are rare and associated with indicators of overtesting. #rheumatology
FYI, I can only tick one option here
July 24, 2025 at 3:41 PM
FYI, I can only tick one option here